[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-106-1-basic-medicine-057":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":23},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"freq":11},"nurse-106-1-基礎醫學-057","nurse-106-1-basic-medicine-057",106,1,57,"下列有關新型抗凝血藥物 Argatroban 的敘述，何者正確？",{"A":15,"B":16,"C":17,"D":18},"經由注射方式給藥","主要抑制第十凝血因子","血漿中必須有 antithrombin III 存在才有抗凝血活性","不經肝臟代謝直接由腎臟排除","A",null,[],"本題考點為新型抗凝血藥 Argatroban 的特性。依抗凝血藥理,Argatroban 為直接凝血酶(第二凝血因子)抑制劑,分子小可直接與凝血酶結合,採靜脈注射給藥,故正解為 A。其抑制的是凝血酶而非第十凝血因子(第十 a 抑制劑為 rivaroxaban 等),B 錯。作為直接抑制劑,不需 antithrombin III 存在即有活性,此點與 heparin 恰相反,C 錯。Argatroban 主要經肝臟代謝而非由腎臟排除,腎功能不全者仍可用,D 錯。",[24,27,31,35,39,43],{"webId":25,"stem":26,"number":11,"year":10,"session":11},"nurse-106-1-basic-medicine-001","下列有關表皮的敘述，何者正確？",{"webId":28,"stem":29,"number":30,"year":10,"session":11},"nurse-106-1-basic-medicine-002","下列何者在組織學特徵上可區分為絲球帶（zona glomerulosa）、束狀帶（zona fasciculata）、網狀帶（zona reticularis）？",2,{"webId":32,"stem":33,"number":34,"year":10,"session":11},"nurse-106-1-basic-medicine-003","顴弓（zygomatic arch）是由顴骨與下列何者共同組成？",3,{"webId":36,"stem":37,"number":38,"year":10,"session":11},"nurse-106-1-basic-medicine-004","下列何者參與形成踝關節？",4,{"webId":40,"stem":41,"number":42,"year":10,"session":11},"nurse-106-1-basic-medicine-005","下列何者是維持背部直立最重要的肌肉？",5,{"webId":44,"stem":45,"number":46,"year":10,"session":11},"nurse-106-1-basic-medicine-006","行走於前臂的內側，並與上臂深層的靜脈會合成腋靜脈的是那一條血管？",6,1783840732343]